Translational Research: Target Identification

One of the first steps in discovering a new therapeutic is identifying a specific molecular target or phenotypic readout for which there is sufficient evidence that it plays a key role in disease progression or symptomology. This may involve approaches utilizing transgenic animals, monitoring signal transduction networks in ex vivo human samples, or genetic studies.

NIDDK-Specific Funding Opportunities

Related Resources

Staff Contacts

For general advice on drug target selection, contact Dr. Aaron Pawlyk.
For disease area expertise, please review the Research Programs and Contacts page.